OT Tracer 25 October 2021

[Audio] Heel Dressing Cost Analysis: Device vs Disposable (2024–2025) Comparing expenses & benefits in heel wound care Al Qassimi Hospital Welcome everyone. Today, we'll be discussing the cost analysis of heel dressing—comparing reusable devices versus disposable silicon foam dressings for outpatient care at Al Qassimi Hospital. Our goal is to understand the financial and clinical implications for 2024–2025..

[Audio] Purpose of the Analysis Objective of Analysis Evaluate the cost-effectiveness of disposable silicon foam dressing versus reusable devices for outpatient heel care in 2024-2025. Key Metrics Focus on total annual cost, patient volume, and potential savings under different device issuance scenarios. Financial and Clinical Impact Analysis identifies break-even points and supports informed decisions on resource allocation and cost optimization. Actionable Recommendations Provides outpatient departments with strategies that align economic efficiency with clinical care priorities. The purpose of this analysis is to evaluate cost-effectiveness between disposable dressings and reusable devices. We focused on key metrics like total annual cost, patient volume, and potential savings under different issuance scenarios. This study aims to identify break-even points and provide actionable recommendations for resource allocation..

[Audio] Disposable Cost (AED) 2024 2025 134112 272283 Device Cost (1 per patient) (AED) 2024 2025 53280 90000 Device Cost (2 per patient) (AED) 2024 2025 106560 180000 Year Total Patients Disposable Cost (AED) Device Cost (1 per patient) Device Cost (2 per patient) Net Savings (1 device) Net Savings (2 devices) 2024 74 134,112 53,280 106,560 80,832 27,552 2025 125 272,283 90,000 180,000 182,283 92,283 Here we compare costs for 2024 and 2025. For example, in 2024, disposable dressings cost AED 134,112, while issuing one device per patient costs AED 53,280—resulting in savings of AED 80,832. Similarly, in 2025, savings increase significantly with higher patient volume. The chart illustrates these differences clearly..

[Audio] Net Savings (1 Device) 2024 2025 80832 182283 Net Savings (2 Devices) 2024 2025 27552 92283 Year Patients Exceeding 1 Device Cost Patients Exceeding 2 Device Cost Potential Savings (1 device) Potential Savings (2 devices) 2024 55 35 86,549 54,973 2025 88 64 190,707 138,248 This slide shows potential savings based on patients exceeding cost thresholds. For instance, in 2025, 88 patients exceeded the cost of one device, leading to potential savings of AED 190,707. This reinforces the financial advantage of device issuance..

[Audio] Optimal Strategy for Device Issuance Cost-Effective Single Device Issuance Issuing one device per outpatient is most cost-effective, saving AED 80,832 in 2024 and AED 182,283 in 2025. Selective Two-Device Issuance Two-device issuance suits patients with bilateral risk but yields lower savings and requires clinical justification. Predictive Analytics & Training Use predictive analytics to forecast high-risk patients and train staff on cost-awareness and selection criteria. Our recommendation is to issue one device per outpatient, which is most cost-effective. Two-device issuance should be reserved for patients with bilateral risk and requires clinical justification. Additionally, predictive analytics and staff training can help optimize selection and cost-awareness..

[Audio] Cost and Savings Charts Cost Comparison Overview Charts highlight the significant cost differences between disposable dressings and device issuance models over two years. Savings Analysis One-device issuance consistently yields higher net savings compared to two-device issuance across the years studied. These charts summarize cost and savings trends. As you can see, one-device issuance consistently delivers higher savings compared to two-device issuance across both years..

[Audio] Thank You Thank you for your attention. We believe these insights will help improve both economic efficiency and patient care..